XORTX Initiates Precision Medicine Program

MT NewswiresOct 9 06:32 ET

XORTX Surges 62% in U.S. Premarket as Peer-Reviewed Research Backs Company's Approach to Polycystic Kidney Disease

MT NewswiresAug 29 08:09 ET

Stocks in Play: XORTX Therapeutics Inc.

Baystreet.caMay 17 11:15 ET

XORTX Therapeutics Reprices Warrants Connected With U.S. IPO

MT NewswiresMay 17 08:16 ET

XORTX Therapeutics Announces Publication of Key Research in ADPKD in Peer-reviewed Journal

MT NewswiresApr 22 07:44 ET

Press Release: XORTX Announces New Clinical Advisory Board Member

Dow JonesMar 27 05:37 ET